Free Trial

Hinge Health (HNGE) Stock Forecast & Price Target

Hinge Health logo
$44.87 +0.34 (+0.76%)
As of 06/26/2025 03:58 PM Eastern

Hinge Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
13

Based on 13 Wall Street analysts who have issued ratings for Hinge Health in the last 12 months, the stock has a consensus rating of "Buy." Out of the 13 analysts, 13 have given a buy rating for HNGE.

Consensus Price Target

$46.00
2.52% Upside
According to the 13 analysts' twelve-month price targets for Hinge Health, the average price target is $46.00. The highest price target for HNGE is $52.00, while the lowest price target for HNGE is $41.00. The average price target represents a forecasted upside of 2.52% from the current price of $44.87.
Get the Latest News and Ratings for HNGE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Hinge Health and its competitors.

Sign Up

HNGE Analyst Ratings Over Time

TypeCurrent Forecast
6/27/24 to 6/27/25
1 Month Ago
5/28/24 to 5/28/25
3 Months Ago
3/29/24 to 3/29/25
1 Year Ago
6/28/23 to 6/27/24
Strong Buy
0 Strong Buy rating(s)
N/A N/A N/A
Buy
13 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price Target$46.00N/AN/AN/A
Forecasted Upside2.52% UpsideN/AN/AN/A
Consensus Rating
Buy
N/AN/AN/A

HNGE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HNGE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Hinge Health Stock vs. The Competition

TypeHinge HealthMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.81
2.53
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside2.52% Upside8,115.44% Upside12.83% Upside
News Sentiment Rating
Neutral News

See Recent HNGE News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/16/2025William Blair
2 of 5 stars
Ryan Daniels
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
6/16/2025Truist Financial
3 of 5 stars
Jailendra Singh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$48.00+38.09%
6/16/2025Stifel Nicolaus
4 of 5 stars
David Grossman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$48.00+38.09%
6/16/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rishi Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$45.00+29.46%
6/16/2025Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$45.00+29.46%
6/16/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jessica Tassan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$41.00+17.95%
6/16/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Craig Hettenbach
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$46.00+32.34%
6/16/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$50.00+43.84%
6/16/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$42.00+20.83%
6/16/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ryan MacDonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$47.00+35.21%
6/16/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Scott Schoenhaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$45.00+29.46%
6/16/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Richard Close
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$52.00+49.60%
6/16/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Saket Kalia
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$43.00+23.71%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 09:18 AM ET.


HNGE Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Hinge Health is $46.00, with a high forecast of $52.00 and a low forecast of $41.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hinge Health in the last twelve months. There are currently 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HNGE shares.

According to analysts, Hinge Health's stock has a predicted upside of 2.52% based on their 12-month stock forecasts.

Analysts like Hinge Health more than other "medical" companies. The consensus rating for Hinge Health is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HNGE compares to other companies.


This page (NYSE:HNGE) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners